Table 1 All EYA4 variants found in this study.

From: Prevalence and clinical features of hearing loss caused by EYA4 variants

#

RefSeq ID

Nucleotide Change

Amino Acid Change

Exon

Domain

Genomic position (GRCh37.p5)

SIFT

PolyPhen2_HVIR

PolyPhen2_HVAR

LRT

Mut _Taster

Mut _Assessor

FATHMM

Meta SVM

Meta LR

CADD_Phred

Allele Frequency (Exac03)

 

ACMG criteria (supporting evidence)

Likely causative

                 

1

NM_004100

c.222_223del

p.T74fs

5

V

133769262

          

0

 

Likely Pathogenic (PVS1 + PM2)

2

NM_004100

c.498delG

p.Q166fs

8

V

133783533

          

0

 

Likely Pathogenic (PVS1 + PM2)

3

NM_004100

c.517C > T

p.Q173X

8

V

133783552

   

0.843

0.810

    

39.000

0

 

Likely Pathogenic (PVS1 + PM2 + PP3)

4

NM_004100

c.580 + 1G > A

 

intron 8

V

133783616

    

0.810

    

26.200

0

 

Likely pathogenic(PVS1 + PM2 + PP3)

5

NM_004100

c.910delC

p.P304fs

11

V

133789809

          

0

 

Likely Pathogenic (PVS1 + PM2)

6

NM_004100

c.988C > T

p.Q330X

12

V

133802618

   

0.843

0.810

    

47.000

0

 

Likely Pathogenic (PVS1 + PM2 + PP3)

7

NM_004100

c.1109G > C

p.R370P

13

E

133804171

0.912

0.899

0.971

0.629

0.810

0.888

0.975

0.995

0.984

34.000

0

 

VUS (PM2 + PP3)

8

NM_004100

c.1177C > T

p.Q393X

13

E

133804239

   

0.843

0.810

    

46.000

0.000008253

0.00009639(AFR)

Pathogenic (PVS1 + PS1 + PP3)

9

NM_004100

c.1216G > C

p.G406R

14

E

133827268

0.912

0.764

0.693

0.629

0.810

0.907

0.808

0.897

0.885

29.800

0

 

VUS (PM2 + PP3)

10

NM_004100

c.1663G > C

p.A555P

18

E

133844240

0.784

0.899

0.916

0.843

0.810

0.865

0.975

0.989

0.985

32.000

0

 

VUS (PM2 + PP3)

11

NM_004100

  

CNV

 

133782193–133789881

            

Likely pathogenic (PVS1 + PM2)

12

NM_004100

  

CNV

 

133756417–133852199

            

Likely pathogenic (PVS1 + PM2)

Unlikely causative

                   

13

NM_004100

c.278T > C

p.M93T

6

V

133777694

0.153

0.090

0.127

0.305

0.810

0.065

0.623

0.514

0.500

14.76 *

0

 

VUS (PM2)

14

NM_004100

c.887C > T

p.S296L

11

V

133789786

0.721

0.548

0.533

0.629

0.537

0.741

0.853

0.816

0.812

23.600

0.00001651 **

0.0002(EAS) **

VUS (PP3)

15

NM_004100

c.936G > T

p.L312F

11

V

133789835

0.491

0.764

0.764

0.843

0.810

0.805

0.862

0.800

0.842

23.000

0.00001651 **

0.0002(EAS) **

VUS (PP3)

16

NM_004100

c.995C > T

p.P332L

12

V

133802625

0.348

0.764

0.739

0.843

0.810

0.684

0.953

0.970

0.972

27.900

0.000008264 **

0.0001(EAS) **

VUS (PS1 + PP3)

17

NM_004100

c.1790delT

p.V597fs

19

E

133846343

          

0

 

Pathogenic (PVS1 *** + PS1 + PM2)

18

NM_004100

c.1886_1899del

p.A629fs

20

E

133849909

          

0

 

VUS (PVS1 *** + PM2)

  1. Abbreviation: V, variable region; E, Eya domain.
  2. *CADD score is low.
  3. **MAF is too high.
  4. ***These variants are unlikely causative because nonsense-mediated mRNA decay is not presumed to be triggered from the location of the variants (see Discussion section).